jcm-logo

Journal Browser

Journal Browser

Diagnosis, Treatment and Prognosis of Coronary Heart Disease: 2nd Edition

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: closed (25 April 2026) | Viewed by 705

Editor


E-Mail Website
Guest Editor
Cardiology Department, Cannizzaro Hospital, 95126 Catania, Italy
Interests: coronary artery disease; cardiovascular intensive care; anthitrombotic therapy
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

It is my pleasure to invite you to contribute to the Special Issue entitled "Diagnosis, Treatment and Prognosis of Coronary Heart Disease: 2nd Edition". This is a new edition; we published nine papers in the first edition. For more details, please visit https://www.mdpi.com/journal/jcm/special_issues/6MI2JAR36K

Despite the advancements in diagnostic and therapeutic approaches over the past decades, coronary heart disease (CHD) remains the leading cause of morbidity and mortality worldwide. Current diagnosis and treatment emphasize the importance of a holistic approach that includes effective and timely preventive measures, early diagnosis, preferably through non-invasive methods, the optimization of medical therapy based on current scientific evidence, and coronary revascularization through PCI or CABG where indicated. Emerging data regarding potential prognostic improvements in CHD are coming from new areas of intervention, such as precision medicine, minimally invasive procedures, stem cell therapy, and the clinical application of artificial intelligence.

We invite manuscripts describing the latest information on coronary heart disease diagnosis, treatment, and prognosis, including original clinical studies and reviews.

Dr. Simona Giubilato
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • coronary heart disease
  • acute coronary syndrome
  • chronic coronary syndrome
  • ischemia with no obstructive coronary arteries (INOCA)
  • guideline-directed optimal medical therapy
  • precision medicine
  • artificial intelligence
  • interventional cardiology
  • percutaneous coronary intervention (PCI)

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

12 pages, 1065 KB  
Article
Erythrocyte and Platelet Indices at Admission and Discharge Stratify Long-Term Cardiovascular Risk After Invasive Treatment of Myocardial Infarction
by Christoph Strohhofer, Faisal Aziz, Andreas Kainz, Andrea Berghold, Nicolas Verheyen, Heiko Bugger, Stefan Hatzl, Raffaela Planka, Friederike von Lewinski, Johannes Gollmer, Klemens Ablasser, Ivan Vosko, Michael Sacherer, Gabor G. Toth, Ewald Kolesnik, Andreas Zirlik, Harald Sourij and Dirk von Lewinski
J. Clin. Med. 2026, 15(12), 4455; https://doi.org/10.3390/jcm15124455 - 9 Jun 2026
Viewed by 358
Abstract
Background/Objectives: Cardiovascular risk remains substantial after myocardial infarction (MI) despite established clinical risk markers. Erythrocyte and platelet indices are routinely available, but their long-term prognostic relevance remains insufficiently studied. Methods: This retrospective cohort study was based on the Styrian Registry on [...] Read more.
Background/Objectives: Cardiovascular risk remains substantial after myocardial infarction (MI) despite established clinical risk markers. Erythrocyte and platelet indices are routinely available, but their long-term prognostic relevance remains insufficiently studied. Methods: This retrospective cohort study was based on the Styrian Registry on Genuine Myocardial Infarction (STRONG-MI) and included patients with MI undergoing invasive coronary angiography in Styria, Austria, between January 2007 and March 2016. Multivariable Cox regression models were used to assess the associations of admission and discharge erythrocyte and platelet indices with 3-point major adverse cardiovascular events (MACE) during follow-up extending to 175 months. Results: Among 10,920 patients, admission hemoglobin showed a U-shaped association with MACE. Median hemoglobin decreased from admission to discharge (14.2 g/dL vs. 13.1 g/dL) and the lowest discharge tertile showed the highest association with MACE compared with the middle tertile (AHR 1.27, 95% CI 1.18–1.38). Lower mean corpuscular hemoglobin concentration (MCHC) was independently linked to adverse outcomes at both admission and discharge (AHR 1.17, 95% CI 1.08–1.27, and 1.14, 95% CI 1.05–1.23, respectively). Higher platelet count and mean platelet volume (MPV) were also associated with increased risk, particularly at discharge (AHR 1.15, 95% CI 1.06–1.24, and 1.19, 95% CI 1.10–1.29, respectively). Conclusions: Routine erythrocyte and platelet indices were independently associated with long-term cardiovascular outcomes after invasively treated MI and reflect residual biological risk after discharge. Full article
Show Figures

Figure 1

Back to TopTop